Literature DB >> 11388242

Transformation of nonvascular acellular tissue matrices into durable vascular conduits.

D R Clarke1, R M Lust, Y S Sun, K S Black, J D Ollerenshaw.   

Abstract

BACKGROUND: Prosthetic grafts commonly used for vascular reconstruction are limited to synthetics and cross-linked tissue grafts. Within these devices, graft infections are common, compliance mismatch is significant, and handling qualities are poor. Natural biological tissues that are unfixed have been shown to resist infections and be durable and compliant. A natural biological matrix that could be remodeled appropriately after implantation would be a desirable graft for vascular reconstruction.
METHODS: SynerGraft tissue engineering strategies have been used to minimize antigenicity and produce stable unfixed vascular grafts from nonvascular bovine tissues. These grafts have replaced the abdominal aortas of 8 dogs that have been followed for up to 10 months.
RESULTS: Early evaluation indicates rapid recellularization by recipient smooth muscle actin positive cells, which become arranged circumferentially, into the media. Arterioles were present in the adventitial areas and endothelial cells were seen to cover lumenal surfaces. After 10 months, grafts were patent and not aneurysmal.
CONCLUSIONS: These data indicate that SynerGraft processing of animal tissues is capable of producing stable vascular conduits that exhibit long-term functionality in other species.

Entities:  

Mesh:

Year:  2001        PMID: 11388242     DOI: 10.1016/s0003-4975(01)02556-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  Engineering of bypass conduits to improve patency.

Authors:  S T Rashid; H J Salacinski; B J Fuller; G Hamilton; A M Seifalian
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

Review 2.  [Tissue engineering for heart valves and vascular grafts].

Authors:  O E Teebken; M Wilhelmi; A Haverich
Journal:  Chirurg       Date:  2005-05       Impact factor: 0.955

3.  Decellularized ureter for tissue-engineered small-caliber vascular graft.

Authors:  Yuji Narita; Hideaki Kagami; Hiroshi Matsunuma; Yosuke Murase; Minoru Ueda; Yuichi Ueda
Journal:  J Artif Organs       Date:  2008-07-06       Impact factor: 1.731

4.  Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.

Authors:  Vivek A Kumar; Luke P Brewster; Jeffrey M Caves; Elliot L Chaikof
Journal:  Cardiovasc Eng Technol       Date:  2011-09-01       Impact factor: 2.495

5.  The use of three-dimensional nanostructures to instruct cells to produce extracellular matrix for regenerative medicine strategies.

Authors:  Katja Schenke-Layland; Fady Rofail; Sanaz Heydarkhan; Jessica M Gluck; Nilesh P Ingle; Ekaterini Angelis; Chang-Hwan Choi; William R MacLellan; Ramin E Beygui; Richard J Shemin; Sepideh Heydarkhan-Hagvall
Journal:  Biomaterials       Date:  2009-06-12       Impact factor: 12.479

6.  Blood vessel-derived acellular matrix for vascular graft application.

Authors:  Luigi Dall'Olmo; Ilenia Zanusso; Rosa Di Liddo; Tatiana Chioato; Thomas Bertalot; Enrica Guidi; Maria Teresa Conconi
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

Review 7.  MicroRNAs in vascular tissue engineering and post-ischemic neovascularization.

Authors:  Massimo Caputo; Jaimy Saif; Cha Rajakaruna; Marcus Brooks; Gianni D Angelini; Costanza Emanueli
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

Review 8.  In Vivo Performance of Decellularized Vascular Grafts: A Review Article.

Authors:  Chih-Hsun Lin; Kai Hsia; Hsu Ma; Hsinyu Lee; Jen-Her Lu
Journal:  Int J Mol Sci       Date:  2018-07-19       Impact factor: 5.923

9.  Concise Review: Patency of Small-Diameter Tissue-Engineered Vascular Grafts: A Meta-Analysis of Preclinical Trials.

Authors:  Ida Skovrind; Eva Bang Harvald; Helene Juul Belling; Christian Damsgaard Jørgensen; Jes Sanddal Lindholt; Ditte Caroline Andersen
Journal:  Stem Cells Transl Med       Date:  2019-03-28       Impact factor: 6.940

10.  Nucleotide Catabolism on the Surface of Aortic Valve Xenografts; Effects of Different Decellularization Strategies.

Authors:  Barbara Kutryb-Zajac; Ada H Y Yuen; Zain Khalpey; Paulina Zukowska; Ewa M Slominska; Patricia M Taylor; Steven Goldstein; Albert E Heacox; Marialuisa Lavitrano; Adrian H Chester; Magdi H Yacoub; Ryszard T Smolenski
Journal:  J Cardiovasc Transl Res       Date:  2016-02-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.